cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 39.1% in January

cbdMD, Inc. (NYSEAMERICAN:YCBD) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totaling 752,043 shares, a decrease of 39.1% from the December 31st total of 1,234,477 shares. Based on an average daily volume of 1,242,503 shares, the days-to-cover ratio is presently 0.6 days. Currently, 7.3% of the shares of the stock are short sold. Currently, 7.3% of the shares of the stock are short sold. Based on an average daily volume of 1,242,503 shares, the days-to-cover ratio is presently 0.6 days.

Insider Transactions at cbdMD

In other news, major shareholder Clark R. Crosnoe sold 550,701 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $2.32, for a total transaction of $1,277,626.32. Following the sale, the insider owned 17,875 shares of the company’s stock, valued at $41,470. This trade represents a 96.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.10% of the company’s stock.

cbdMD Stock Performance

Shares of NYSEAMERICAN YCBD opened at $0.79 on Friday. The company’s 50 day moving average price is $1.02 and its 200-day moving average price is $0.92. cbdMD has a 52-week low of $0.47 and a 52-week high of $5.48.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.